Noom unveils two new enterprise products to help employers offer, manage, and effectively control glp-1 expenses

Noom med with smart rx , in partnership with waltz health, drives significant roi for employers who wish to cover glp-1s as a supplemental benefit such that the payer can choose the level of financial assistance they will provide noom weight with glp-1 rx delivers a proven obesity program and employee-pay access to affordable glp-1s for employers who choose not to cover glp-1s today new york, oct. 21, 2024 (globe newswire) -- noom , the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, is tackling the problem of glp-1 availability, accessibility and inflated costs head-on by launching two distinct enterprise solutions that reduce obesity management costs while enabling access to life-changing medications: noom med with smart rx in partnership with  waltz health and noom weight with glp-1 rx . both options support different budgets and organizational priorities to reduce glp-1 medication costs and lower overall healthcare expenditures.
EPD Ratings Summary
EPD Quant Ranking